Exelixis (EXEL) is down -12.5%, or -$4.89 to $34.36.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EXEL:
- Morning Movers: Cleveland-Cliffs surges following earnings report
- Exelixis’s Zanza: A Strong Contender with Promising Survival Rates and Manageable Safety Profile
- Exelixis reports detailed results from STELLAR-303
- Exelixis announces results from analysis of CABINET Phase 3 trial of CABOMETYX
- Exelixis: Buy Rating Backed by Strategic Positioning and Growth Prospects